HKD 3.49
(4.18%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.42 Billion CNY | 7.27% |
2022 | 1.33 Billion CNY | 25.63% |
2021 | 1.06 Billion CNY | 113.68% |
2020 | 496.21 Million CNY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 1.26 Billion CNY | 0.0% |
2024 Q1 | 1.26 Billion CNY | -11.57% |
2023 Q3 | 1.42 Billion CNY | 6.14% |
2023 FY | 1.42 Billion CNY | 7.27% |
2023 Q1 | 1.34 Billion CNY | 1.07% |
2023 Q2 | 1.34 Billion CNY | 0.0% |
2023 Q4 | 1.42 Billion CNY | 0.0% |
2022 Q3 | 1.33 Billion CNY | 0.0% |
2022 Q4 | 1.33 Billion CNY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Uni-Bio Science Group Limited | 409.99 Million HKD | -248.515% |
CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 87.296% |